Skip to content
Search

Latest Stories

Chief pharmacist for England answers questions on professional leadership commission

Chief pharmacist for England and a co-chair on the professional leadership commission has responded to the questions raised by Pharmacists Defence Association (PDA) members on professional leadership.

In early September, the PDA wrote to the UK’s Chief Pharmaceutical Officers to increase transparency and confidence in the process by asking for clarification of some of the commission’s thinking, assumptions, and scope.


On behalf of all four CPhOs, chief pharmacist for England, David Webb, provided his feedback, saying: “The Commission has two independent co-chairs and members have agreed to abide by the seven principles for the conduct of public life as recommended by the Nolan Commission which forms part of the Terms of Reference.

"Commission members have been appointed on behalf of all pharmacy professionals to contribute their expertise in and knowledge of professional leadership and are not appointed to represent their particular countries, organisations, sectors or roles.

“The CPhOs act as advisors to the Commission and the final report will be authored by the co-chairs in consultation with Commission members. A Call for Evidence survey analysis and report writing is being conducted by an independent external organisation.

He said the survey was not intended to focus on any specific professional leadership body but that were were many such bodies that relate to pharmacy professionals across the UK.

“The work is being funded by the Offices of the four UK chief pharmaceutical officers.”

Later, the commission also shared a response on PDA’s members question on what was meant by “pharmacy professionals”? What prompted the formation of the commission and what expertise do individual members of the commission have?

Their response stated:

  • “The Commission was set up by the CPhOs with the broad aim to support and strengthen pharmacy professional leadership to enable excellence in patient care. There are significant changes occurring – and which will continue to evolve – which impact on the pharmacist and pharmacy technician professions and we need to ensure that they are well equipped with a voice to help shape the future, and enabled to develop through determining best practice, sharing and learning from it.  Strong, effective and well-respected professional leadership, which represents the clinical voice of pharmacy professionals, is required to guide, support and enable these transformational changes so they benefit patients and professionals. The final recommendations of the Report of the Commission are a matter for the Co-Chairs.”
  • “It is an independent Commission, co-chaired by independent non pharmacy professionals, with significant expertise and experience in professional regulation and leadership.”
  •  “The Commission members have been invited to participate based on their knowledge and expertise in professional leadership in its various guises.”
  • “All pharmacy professional leadership bodies are included – the RPS, APTUK and PSNI; to this should be added all those groupings who represent pharmacists in particular areas of practice, such as the British Oncology Pharmacy Association, and the UKCPA, for example.”
  •  “Pharmacy professionals are registered pharmacists and pharmacy technicians.”

However, the response came in too late to be shared, just a few hours before the midnight deadline for submissions.

Details of the full range of questions asked by PDA members and the rationale can be found here.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less